行情

SURF

SURF

SURFACE ONCOLOGY
NASDAQ

实时行情|Nasdaq Last Sale

1.900
-0.150
-7.32%
已收盘, 16:00 09/18 EDT
开盘
2.070
昨收
2.050
最高
2.076
最低
1.900
成交量
1.81万
成交额
--
52周最高
12.65
52周最低
1.850
市值
5,287.62万
市盈率(TTM)
-1.2001
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SURF 新闻

  • 沪指尾盘拉升 美联储宣布降息、美股先抑后扬
  • 新浪财经.1小时前
  • 瑞士央行将利率维持在负值区域,并下调经济增长预期
  • 环球外汇网官网.1小时前
  • 历史上的两次大崩盘,罪魁祸首竟然都是金融创新!
  • 新浪财经-自媒体综合.1小时前
  • 国际原油市场恢复平静,IEA发声稳定军心
  • 汇通网.1小时前

更多

所属板块

生物技术和医学研究
-0.65%
制药与医学研究
-0.05%

热门股票

名称
价格
涨跌幅

SURF 简况

Surface Oncology, Inc. is a clinical-stage immuno-oncology company. The Company is engaged in the development of cancer immunotherapies. To unlock the potential of cancer immunotherapy, the Company is targeting a set of immune processes by which cancer cells evade immune recognition and attack. Its programs are built upon insights about how to improve the immune system’s recognition and elimination of cancer cells. These include approaches to improve the effectiveness of antigen presentation to the adaptive immune system, to block the activity of a range of suppressor cells in the tumor microenvironment, and to counter the immunosuppressive environment that selectively accumulates in and around the tumor. By targeting the interface of innate and adaptive immunity, it hopes to expand the reach of cancer immunotherapy to patients in need of treatment.
展开

Webull提供Surface Oncology Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。